Stamford, CT -- (SBWIRE) -- 12/07/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Newcastle Investment Corp. (NYSE:NCT), SeaChange International (NASDAQ:SEAC), Unilife Corp (NASDAQ:UNIS), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Newcastle Investment Corp. (NYSE:NCT) ended higher +1.69% from its previous close of $5.34 and complete the day at $5.43. The total number of shares changed hands during the day was 2.63 million. After opening at $5.31, the stock hit as high as $5.45. However, it traded between $4.70 and $12.49 over the last twelve months.
Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained negative -1.63% during the previous three months trade. Newcastle Investment Corp. operates as a real estate investment and finance company in the United States. The company invests in and manages a portfolio consisting of real estate securities; loans; excess mortgage servicing rights; and real estate related assets, such as senior living facilities, and other assets.
For How Long NCT will Fight for Profitability? Read This Trend Analysis report
SeaChange International (NASDAQ:SEAC) closed yesterday at $12.03, a -16.46% decrease. Around 2.60 million shares were traded, beating an-average trading volume of 245,313 shares. The company is now valued at around $395.40 million. The stock opened the session at $12.59 and touched its highest price point at $12.59.
SEAC’s lowest price point for the session stood at $11.60 and its 52 week price range stood at $9.10 - $15.25. SeaChange International, Inc. provides multi-screen video products and services that facilitate the aggregation, licensing, management, and distribution of video, television programming, and advertising content to cable system operators, telecommunications companies, broadcast television companies, and mobile communications providers worldwide.
Has SEAC Found The Bottom And Ready To Gain Momentum? Find Out Here
Unilife Corp (NASDAQ:UNIS) moved -4.22 percent lower at $4.31 and traded between $4.16 and $4.52 after opening the day at $4.45. Its performance over the last five days remained -3.15%, which stands at 63.26% for a month. Going back further than one month, 1-year performance after recent close was 89.87%.
The company has a total of 100.49 million outstanding shares and its total market capitalization is $433.12 million. Its beta value stands at 1.11 times and earnings per share was -$0.73. Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a staked (fixed) retracting needle that is designed for use with liquid stable drugs; Unifill Select for use of liquid stable drug or vaccine, or a diluent to reconstitute and deliver a lyophilized drug supplied in a vial; and Unifill Assure, a finger flange and a thumb press for the intuitive self-injection of biologics.
Why Should Investors Buy UNIS After the Recent Fall? Just Go Here and Find Out
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)’s shares dropped -1.98 percent from its previous close of $6.05 to close at $5.93. The stock is up around 317.61% this year and 244.77% for the last 12 months. Around 2.58 million shares changed hands yesterday, higher from an-average trading volume of 826,774 shares. BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops novel drugs that block key enzymes involved in the pathogenesis of diseases. The company integrates the disciplines of biology, crystallography, medicinal chemistry, and computer modeling to discover and develop small molecule pharmaceuticals through the structure-guided drug design process.
Will BCRX Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)